250 related articles for article (PubMed ID: 8246025)
1. Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature.
Quesnel B; Kantarjian H; Bjergaard JP; Brault P; Estey E; Lai JL; Tilly H; Stoppa AM; Archimbaud E; Harousseau JL
J Clin Oncol; 1993 Dec; 11(12):2370-9. PubMed ID: 8246025
[TBL] [Abstract][Full Text] [Related]
2. Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors?
Dissing M; Le Beau MM; Pedersen-Bjergaard J
J Clin Oncol; 1998 May; 16(5):1890-6. PubMed ID: 9586906
[TBL] [Abstract][Full Text] [Related]
3. Therapy-related acute promyelocytic leukemia: a report on 16 cases.
Detourmignies L; Castaigne S; Stoppa AM; Harousseau JL; Sadoun A; Janvier M; Demory JL; Sanz M; Berger R; Bauters F
J Clin Oncol; 1992 Sep; 10(9):1430-5. PubMed ID: 1517786
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study.
Mrózek K; Prior TW; Edwards C; Marcucci G; Carroll AJ; Snyder PJ; Koduru PR; Theil KS; Pettenati MJ; Archer KJ; Caligiuri MA; Vardiman JW; Kolitz JE; Larson RA; Bloomfield CD
J Clin Oncol; 2001 May; 19(9):2482-92. PubMed ID: 11331327
[TBL] [Abstract][Full Text] [Related]
5. Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroup.
Prébet T; Boissel N; Reutenauer S; Thomas X; Delaunay J; Cahn JY; Pigneux A; Quesnel B; Witz F; Thépot S; Ugo V; Terre C; Recher C; Tavernier E; Hunault M; Esterni B; Castaigne S; Guilhot F; Dombret H; Vey N; ; ;
J Clin Oncol; 2009 Oct; 27(28):4747-53. PubMed ID: 19720919
[TBL] [Abstract][Full Text] [Related]
6. Balanced chromosome abnormalities inv(16) and t(15;17) in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshop.
Andersen MK; Larson RA; Mauritzson N; Schnittger S; Jhanwar SC; Pedersen-Bjergaard J
Genes Chromosomes Cancer; 2002 Apr; 33(4):395-400. PubMed ID: 11921273
[TBL] [Abstract][Full Text] [Related]
7. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001.
Mauritzson N; Albin M; Rylander L; Billström R; Ahlgren T; Mikoczy Z; Björk J; Strömberg U; Nilsson PG; Mitelman F; Hagmar L; Johansson B
Leukemia; 2002 Dec; 16(12):2366-78. PubMed ID: 12454741
[TBL] [Abstract][Full Text] [Related]
8. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H
J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833
[TBL] [Abstract][Full Text] [Related]
9. Spectral karyotyping and fluorescence in situ hybridization analyses identified a novel three-way translocation involving inversion 16 in therapy-related acute myeloid leukemia M4eo.
Ohsaka A; Otsubo K; Yokota H; Hisa T; Saito H; Kozaki T
Cancer Genet Cytogenet; 2008 Jul; 184(2):113-8. PubMed ID: 18617061
[TBL] [Abstract][Full Text] [Related]
10. Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): results from CALGB 8461.
Byrd JC; Ruppert AS; Mrózek K; Carroll AJ; Edwards CG; Arthur DC; Pettenati MJ; Stamberg J; Koduru PR; Moore JO; Mayer RJ; Davey FR; Larson RA; Bloomfield CD
J Clin Oncol; 2004 Mar; 22(6):1087-94. PubMed ID: 15020610
[TBL] [Abstract][Full Text] [Related]
11. Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.
Larson RA; Le Beau MM
Chem Biol Interact; 2005 May; 153-154():187-95. PubMed ID: 15935816
[TBL] [Abstract][Full Text] [Related]
12. Dual color FISH on CBF primary acute myeloid leukemia.
Sorour A; Nafea D
Egypt J Immunol; 2008; 15(2):25-31. PubMed ID: 20306685
[TBL] [Abstract][Full Text] [Related]
13. Variable prognostic value of FLT3 internal tandem duplications in patients with de novo AML and a normal karyotype, t(15;17), t(8;21) or inv(16).
Kainz B; Heintel D; Marculescu R; Schwarzinger I; Sperr W; Le T; Weltermann A; Fonatsch C; Haas OA; Mannhalter C; Lechner K; Jaeger U
Hematol J; 2002; 3(6):283-9. PubMed ID: 12522450
[TBL] [Abstract][Full Text] [Related]
14. High frequency of pro-B acute lymphoblastic leukemia in adults with secondary leukemia with 11q23 abnormalities.
Ishizawa S; Slovak ML; Popplewell L; Bedell V; Wrede JE; Carter NH; Snyder DS; Arber DA
Leukemia; 2003 Jun; 17(6):1091-5. PubMed ID: 12764373
[TBL] [Abstract][Full Text] [Related]
15. [Clinical and experimental studies of childhood acute myeloid leukemia with 11q23/MLL rearrangements].
He YX; Xue YQ; Wang HY; Shao XJ; Pan JL; Xu J; Yang NC; Ji ZH; Huang YP; Hu SY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):677-82. PubMed ID: 23225048
[TBL] [Abstract][Full Text] [Related]
16. Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation.
Sandoval C; Pui CH; Bowman LC; Heaton D; Hurwitz CA; Raimondi SC; Behm FG; Head DR
J Clin Oncol; 1993 Jun; 11(6):1039-45. PubMed ID: 8388919
[TBL] [Abstract][Full Text] [Related]
17. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements.
Andersen MK; Johansson B; Larsen SO; Pedersen-Bjergaard J
Haematologica; 1998 Jun; 83(6):483-8. PubMed ID: 9676019
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic and clinical correlates in AML patients with abnormalities of chromosome 16.
Marlton P; Keating M; Kantarjian H; Pierce S; O'Brien S; Freireich EJ; Estey E
Leukemia; 1995 Jun; 9(6):965-71. PubMed ID: 7596186
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetically cryptic AML1-ETO and CBF beta-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemia.
Rowe D; Cotterill SJ; Ross FM; Bunyan DJ; Vickers SJ; Bryon J; McMullan DJ; Griffiths MJ; Reilly JT; Vandenberghe EA; Wilson G; Watmore AE; Bown NP
Br J Haematol; 2000 Dec; 111(4):1051-6. PubMed ID: 11167739
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of karyotype in de novo adult acute myeloid leukemia. The BGMT group.
Dastugue N; Payen C; Lafage-Pochitaloff M; Bernard P; Leroux D; Huguet-Rigal F; Stoppa AM; Marit G; Molina L; Michallet M
Leukemia; 1995 Sep; 9(9):1491-8. PubMed ID: 7658718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
